Haemonetics Corporation announced that the Company intends to publish third quarter fiscal year 2022 financial results at 6:00 am EST on Tuesday, February 8, 2022.
BOSTON, Jan. 5, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish third quarter fiscal year 2022 financial results at 6:00 am EST on Tuesday, February 8, 2022. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am EST on February 8, 2022.
The call can be accessed with the following information:
U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
Conference ID required for access: 1649685
A live webcast of the call can be accessed on Haemonetics’ investor relations website. Webcast Link: https://edge.media-server.com/m6/p/qyrbnnofhttps://edge.media-server.com/mmc/p/qdj4xoqw
A replay of the conference call and webcast will be available for one year beginning on February 8, 2022 at 11:00 a.m. EST using the conference call webcast link provided in this press release.
About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
| Investor Contact: | Media Contact: |
| Olga Guyette, Director-Investor Relations | Josh Gitelson, Director-Global Communications |
| (781) 356-9763 | (781) 356-9776 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-third-quarter-fiscal-year-2022-results-february-8-2022-301454100.html
SOURCE Haemonetics Corporation
Company Codes: NYSE:HAE
